Transforming growth factor-β initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform

American Journal of Pathology

Volumn 156, Issue 1, 2000, Pages 115-124

  George, Jacob ^a   Wang, Shao Shean ^a   Sevcsik, Ann Marie ^a   Sanicola, Michele ^b   Cate, Richard L ^b   Koteliansky, Victor E ^b   Bissell, D Montgomery ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIVER INJURY; LIVER SINUSOID; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA ANALYSIS; WOUND HEALING;

EID: 0033874135     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64711-6     Document Type: Article

References (53)

1. TGF-β: Problems and prospects
2. Type β transforming growth factor in human platelets: Release during platelet degranulation and action on vascular smooth muscle cells
3. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth
4. Deactivation of macrophages by transforming growth factor-β
5. Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
6. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix
7. Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts
8. Transforming growth factor β modulates the expression of collagenase and metalloproteinase inhibitor
9. Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase
10. Promoter sequences of the human transforming growth factor-β 1 gene responsive to transforming growth factor-β 1 autoinduction
11. Cell-specific expression of transforming growth factor-β in rat liver: Evidence for autocrine regulation of hepatocyte proliferation
12. The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease
13. Hepatic lipocytes: The principal collagen-producing cells of normal rat liver
14. In vitro and in vivo association of transforming growth factor-β 1 with hepatic fibrosis
15. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor β: Implication for a pathogenetic role in alcoholic liver fibrogenesis
16. Cellular distribution of transforming growth factor-β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis
17. Ito-cell gene expression and collagen regulation
18. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies
19. Transforming growth factor β1-regulated gene expression of Ito cells
20. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo
21. The role of α1β1 integrin in wound contraction A quantitative analysis of liver myofibroblasts in vivo and in primary culture
22. Human fibronectin: Molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain
23. Three different fibronectin mRNAs arise by alternative splicing within the coding region
24. Repeating modular structure of the fibronectin gene: Relationship to protein structure and subunit variation
25. Alternative splicing of fibronectin: Many different proteins but few different functions
26. Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis
27. Localization and mRNA steady-state level of cellular fibronectin in rat liver undergoing a CCl4-induced acute damage or fibrosis
28. Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells
29. Cloning expression and alternative splicing of the receptor for anti-Mullerian hormone
30. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins
31. Immunodetection and quantitation of the two forms of transforming growth factor-β (TGF-β1 and TGF-β2) secreted by cells in culture
32. Degradation of newly synthesized collagen
33. Isolation and culture of hepatic lipocytes Kupffer cells and sinusoidal endothelial cells by density gradient centrifugation with Stractan
34. Characterization and culture of sinusoidal endothelium from normal rat liver: Lipoprotein uptake and collagen phenotype
35. Phenotypic stability of adult rat hepatocytes in primary monolayer culture
36. Primary structure of human ribosomal protein S14 and the gene that encodes it
37. Transcriptional regulation of the A and B chain genes of platelet-derived growth factor in microvascular endothelial cells
38. Expression of the alternatively spliced EIIIB segment of fibronectin
39. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
40. Concerted action of TGF-β 1 and its type II receptor in control of epidermal homeostasis in transgenic mice
41. Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-β1
42. Transforming growth factor βs and wound healing
43. Hepatic expression of mature transforming growth factor β 1 in transgenic mice results in multiple tissue lesions
44. Transforming growth factors β1 and β2 are differentially expressed in fibrotic liver disease
45. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
46. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis
47. Modulation of monocyte type I transforming growth factor-β receptors by inflammatory stimuli
48. Transforming growth factors β1 and α in chronic liver disease: Effects of interferon alfa therapy
49. Role of transforming growth factor β type II receptor in hepatic fibrosis: Studies of human chronic hepatitis C and experimental fibrosis in rats
50. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor β type II receptor: A potential new therapy for hepatic fibrosis
51. Functional association between promoter structure and transcript alternative splicing
52. Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection
53. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1